North Carolina 2017-2018 Session Status: In Committee 1 R cosponsors

SB 347 — Revise Schedule of Controlled Substances.

Last action — Withdrawn From Com

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2017-2018 Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

22 added · 23 removed

Plain-language change summary

The latest version of Senate Bill 347 includes a few updates, primarily adding some background information about the bill's authors and its progression through the legislative process. Specifically, it lists the sponsors of the bill and the dates of its filing and referral. These changes are significant because they provide clarity and context around who is proposing the legislation and when it is being considered, which is important for transparency and accountability in the legislative process.

→
Previous
Latest
FILED SENATE GENERAL ASSEMBLY OF NORTH CAROLINA Mar 21, 2017 S.B.
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 1 SENATE BILL 347* Short Title:
347 SESSION 2017 PRINCIPAL CLERK S D SENATE BILL DRS25039-MG-88A* (03/14) Short Title:
Davis and McInnis (Primary Sponsors).
Davis, McInnis (Primary Sponsors);
and Rabin.
A BILL TO BE ENTITLED AN ACT REVISING THE SCHEDULE OF CONTROLLED SUBSTANCES TO ADD SYNTHETIC FENTANYLS, DESIGNER HALLUCINOGENICS, SYNTHETIC CANNABINOIDS, SYSTEM DEPRESSANTS, AND OTHER SUBSTANCES.
Rules and Operations of the Senate March 22, 2017 A BILL TO BE ENTITLED AN ACT REVISING THE SCHEDULE OF CONTROLLED SUBSTANCES TO ADD SYNTHETIC FENTANYLS, DESIGNER HALLUCINOGENICS, SYNTHETIC CANNABINOIDS, SYSTEM DEPRESSANTS, AND OTHER SUBSTANCES.
*DRS25039-MG-88A* General Assembly Of North Carolina Session 2017 l.
*S347-v-1* General Assembly Of North Carolina Session 2017 l.
Page 2 DRS25039-MG-88A* [v.4] (03/17) General Assembly Of North Carolina Session 2017 aaa.
Page 2 Senate Bill 347*-First Edition General Assembly Of North Carolina Session 2017 aaa.
DRS25039-MG-88A* [v.4] (03/17) Page 3 General Assembly Of North Carolina Session 2017 i.
Senate Bill 347*-First Edition Page 3 General Assembly Of North Carolina Session 2017 i.
Page 4 DRS25039-MG-88A* [v.4] (03/17) General Assembly Of North Carolina Session 2017 u.
Page 4 Senate Bill 347*-First Edition General Assembly Of North Carolina Session 2017 u.
2-(methylamino)- propiophenone, alpha-(methylamino)propiophenone, DRS25039-MG-88A* [v.4] (03/17) Page 5 General Assembly Of North Carolina Session 2017 2-(methy- lamino)-1-phenylpropan-1-one, alpha-N-methylamino- propiophenone, monomethylproprion, ephedrone, N-methylcathinone, methylcathinone, AL-464, AL-422, AL-463, and UR1432.
2-(methylamino)- propiophenone, alpha-(methylamino)propiophenone, Senate Bill 347*-First Edition Page 5 General Assembly Of North Carolina Session 2017 2-(methy- lamino)-1-phenylpropan-1-one, alpha-N-methylamino- propiophenone, monomethylproprion, ephedrone, N-methylcathinone, methylcathinone, AL-464, AL-422, AL-463, and UR1432.
Page 6 DRS25039-MG-88A* [v.4] (03/17) General Assembly Of North Carolina Session 2017 h.
Page 6 Senate Bill 347*-First Edition General Assembly Of North Carolina Session 2017 h.
Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent DRS25039-MG-88A* [v.4] (03/17) Page 7 General Assembly Of North Carolina Session 2017 and whether or not substituted in the naphthyl ring to any extent.
Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent Senate Bill 347*-First Edition Page 7 General Assembly Of North Carolina Session 2017 and whether or not substituted in the naphthyl ring to any extent.
At the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, Page 8 DRS25039-MG-88A* [v.4] (03/17) General Assembly Of North Carolina Session 2017 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group;
At the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, Page 8 Senate Bill 347*-First Edition General Assembly Of North Carolina Session 2017 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group;
DRS25039-MG-88A* [v.4] (03/17) Page 9 General Assembly Of North Carolina Session 2017 whether or not the compound is further modified to any extent in the following ways:
Senate Bill 347*-First Edition Page 9 General Assembly Of North Carolina Session 2017 whether or not the compound is further modified to any extent in the following ways:
At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, Page 10 DRS25039-MG-88A* [v.4] (03/17) General Assembly Of North Carolina Session 2017 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group;
At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, Page 10 Senate Bill 347*-First Edition General Assembly Of North Carolina Session 2017 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group;
DRS25039-MG-88A* [v.4] (03/17) Page 11 General Assembly Of North Carolina Session 2017 d.
Senate Bill 347*-First Edition Page 11 General Assembly Of North Carolina Session 2017 d.
… Page 12 DRS25039-MG-88A* [v.4] (03/17) General Assembly Of North Carolina Session 2017 (k) Anabolic steroids.
… Page 12 Senate Bill 347*-First Edition General Assembly Of North Carolina Session 2017 (k) Anabolic steroids.
If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to DRS25039-MG-88A* [v.4] (03/17) Page 13 General Assembly Of North Carolina Session 2017 have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subsection.
If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to Senate Bill 347*-First Edition Page 13 General Assembly Of North Carolina Session 2017 have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subsection.
Page 14 DRS25039-MG-88A* [v.4] (03/17) General Assembly Of North Carolina Session 2017 gg.
Page 14 Senate Bill 347*-First Edition General Assembly Of North Carolina Session 2017 gg.
DRS25039-MG-88A* [v.4] (03/17) Page 15
Senate Bill 347*-First Edition Page 15
⬇ Download PDF
View plain text versions (2)

Action History

  1. Withdrawn From Com

  2. Re-ref to Judiciary. If fav, re-ref to Rules and Operations of the Senate

  3. Passed 1st Reading

  4. Ref To Com On Rules and Operations of the Senate

  5. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 176 not signed on

Sponsors (1)

Co-sponsors (2)

Not signed on (176)

176 members have not signed on to this bill.

Show all 176 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 347?
SB 347 is sponsored by Rabin, Tom McInnis (Republican), and D. Davis.
What is the current status of SB 347?
This bill died with 2017-2018 Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 347?
Track SB 347 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 347

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 347

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →